Table I.
Tumor volume, mm3 | |||||
---|---|---|---|---|---|
Treatment group | 0 | 7 days | 14 days | 21 days | 28 days |
Control (n=6) | 58.9±6.4 | 85.6±6.8 | 88.7±18.7 | 84.7±12.4 | 102.2±17.6 |
Saline (n=6) | 62.2±7.9 | 98.7±25.9 | 79.0±15.5 | 77.9±24.8 | 94.6±10.5 |
Bevacizumab (n=6) | 70.2±29.5 | 64.9±30.2 | 40.0±10.6 | 48.1±21.2 | 57.1±28.4 |
Tumor volume presented as mean ± SD.